Answers are grounded in this paper and cite their sources.
Introduction Type 2 diabetes is the leading cause of end-stage kidney disease (ESKD), yet long-term trajectories of kidney function from the time of diagnosis‐particularly in individuals with preserved kidney function and no albuminuria‐remain poorly characterized. We aimed to evaluate the long-term risks of incident albuminuria and kidney function decline and to characterize the heterogeneity of early disease progression in adults with newly diagnosed type 2 diabetes. Methods Using the Korean National Health Insurance Service database, we identified 226,265 individuals newly diagnosed with type 2 diabetes in 2012‐2013 and 678,795 matched non-diabetic controls. The primary outcome was a composite kidney outcome (estimated glomerular filtration rate [eGFR] <60 mL/min/1.73 m2, incident albuminuria, dialysis, or kidney transplantation). Trajectory-based clustering was employed to identify distinct patterns of eGFR decline in the type 2 diabetes cohort. Results Over a median 9.1-year follow-up, 12.9% of patients with type 2 diabetes experienced the composite kidney outcome versus 9.4% of controls (absolute risk difference, 3.5%). Type 2 diabetes was associated with higher risks of the composite outcome (adjusted hazard ratio [aHR], 1.20; 95% CI, 1.18-1.22), incident albuminuria (aHR, 1.45; 95% CI, 1.40–1.50), and dialysis or kidney transplantation (aHR, 2.98; 95% CI, 2.59–3.43). Despite the modest mean difference in annual eGFR decline (–0.03 mL/min/1.73 m2/year), trajectory-based clustering revealed substantial heterogeneity. Approximately one-third of patients showed a progressive eGFR decline. Conclusions Although the average annual eGFR decline in newly diagnosed type 2 diabetes was modestly greater than that in the general population, the absolute cumulative risk of the composite kidney outcome was meaningfully higher over long-term follow-up. Substantial heterogeneity in eGFR trajectories suggests that average measures mask high-risk subgroups, highlighting the need for early monitoring and proactive kidney-protective strategies from diagnosis.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: